Saphris: Does a unique delivery system equal a unique drug?

Asenapine was approved by the Food and Drug Administration (FDA) in 2009. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative propert...

Full description

Saved in:
Bibliographic Details
Published in:The mental health clinician 2011-12, Vol.1 (6), p.133-134
Main Author: Gable, Kelly N.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Asenapine was approved by the Food and Drug Administration (FDA) in 2009. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative properties and place in therapy.
ISSN:2168-9709
2168-9709
DOI:10.9740/mhc.n89388